Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Delivery timing determines senomorphic efficacy: delayed local ruxolitinib restores macrophage polarization and rescues age-impaired bone repair.
Journal: Research square
Published: June 04, 2026
Macrophage cell therapy enabled by interleukin-4 mRNA-loaded lipid nanoparticles to sustain a pro-reparative phenotype in inflammatory injuries.
Journal: Biomaterials
Published: April 02, 2025
Effects of injury size on local and systemic immune cell dynamics in volumetric muscle loss.
Journal: NPJ Regenerative medicine
Published: February 28, 2024
Sustained release of drug-loaded nanoparticles from injectable hydrogels enables long-term control of macrophage phenotype.
Journal: Biomaterials science
Published: November 07, 2022
Pro-inflammatory polarization primes Macrophages to transition into a distinct M2-like phenotype in response to IL-4.
Journal: Journal of leukocyte biology
Published: October 13, 2021
Sequential drug delivery to modulate macrophage behavior and enhance implant integration.
Journal: Advanced drug delivery reviews
Published: January 15, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
Journal: Cancer immunology research
Published: June 11, 2018
Perylenequinones: Isolation, Synthesis, and Biological Activity.
Journal: European journal of organic chemistry
Published: July 01, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026